Equity markets trade lower dragged by pharma stocks, relentless foreign fund outflows

Equity benchmark indices Sensex and Nifty declined in early trade on Friday (September 26, 2025) dragged by pharma stocks and relentless foreign fund outflows.

U.S. H-1B visa fee concerns and a weak trend in global markets also added to the bearish trend in domestic equities.

“Investor attention will squarely be on the domestic pharma sector after the Trump Administration announced a 100 per cent tariff on imports of branded or patented pharmaceutical products effective October 1. This tariff action comes close on the heels of the steep hike in US H-1B visa fees, which has already triggered heavy selling in IT sector stocks over the past few sessions,” Ponmudi R, CEO of Enrich Money, an online trading and wealth tech firm, said.

The 30-share BSE Sensex declined 329.66 points to 80,830.02 in early trade. The 50-share NSE Nifty dropped 105.7 points to 24,785.15.

From the Sensex firms, Sun Pharma dropped over 3%. Asian Paints, Tech Mahindra, Infosys, Power Grid, HCL Tech, and Tata Steel were also among the laggards.

However, Larsen & Toubro, Tata Motors, ITC and Trent were the gainers.

In Asian markets, South Korea’s Kospi, Japan’s Nikkei 225 index, Shanghai’s SSE Composite index and Hong Kong’s Hang Seng quoted lower.

U.S. markets ended lower on Thursday.

Foreign Institutional Investors (FIIs) offloaded equities worth ₹4,995.42 crore on Thursday, according to exchange data.

“The sustained FII selling may keep the market under pressure,” V K Vijayakumar, Chief Investment Strategist, Geojit Investments Ltd, said.

Global oil benchmark Brent crude climbed 0.17% to $69.54 a barrel.

On Thursday (September 25, 2025), the Sensex tanked 555.95 points or 0.68% to settle at 81,159.68. The Nifty tumbled 166.05 points or 0.66% to 24,890.85.